PTC Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 62.86 +0.24 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.62 | 52 Week High | $35.40 | |||
| Open | $62.62 | 52 Week Low | $4.03 | |||
| Day High | $63.49 | P/E | 6.69 | |||
| Day Low | $62.24 | EPS | $9.40 | |||
| Volume | 54,707 | |||||
